Precision for Medicine’s Chad Clark, President, and Scott Marshall, Managing Director of Biomarker and IVD Analytics, contribute a new commentary for Bioscience Technology Online on the challenges of biomarker data management. Clark and Marshall make a strong case that translational science is no longer an optional element in modern clinical trials—that comprehensive biomarker data management supports the harmonization of biomarker and specified clinical data by combining subject matter expertise with advanced informatics/technology platforms.
To read the complete article, please click here.